Bioresorbable Coronary Scaffolds Market

Bioresorbable Coronary Scaffolds Market: Global Industry Analysis 2012 - 2016 and Opportunity Assessment; 2017 – 2027

  • Ongoing
  • September 2020
  • REP-GB-3899
  • Format: PDF/PPT/Excel

  • US$5,000
  • US$7,500
  • US$10,000

This Bioresorbable Coronary Scaffolds market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Bioresorbable Coronary Scaffolds market.

Currently available drug eluting coronary stents are associated with better clinical outcomes than bare metal stents and first generation drug eluting stents. However, introduction of first bioresorbable coronary scaffold in 2016 by Abbott Vascular Inc. in the U.S. market is expected to change the landscape of coronary artery disease (CAD) management. Bioresorbable scaffolds are preferred over permanent implants as they reduce device/host interaction, and need for long-term anticoagulation therapy. Bioresorbable scaffold was proposed as a third evolution in coronary artery disease management with aim to reduce recurrence of coronary artery stenosis and incidence of stent thrombosis. Currently available bioresorbable coronary scaffolds include Absorb GT1 (Abbott Vascular Inc.), FORTITUDE (Amaranth Medical, Inc.), DESolve (Elixir Medical Corporation) etc. Moreover, Biotronic Inc. is developing metallic magnesium-based bioresorbable coronary scaffold, which is expected to hit the market by 2020. Even though, technological and clinical development of bioresorbable scaffolds is not yet complete and possible clinical benefits over metallic stents are still unrevealed, there are no solid reasons that can limit the clinical use of these devices.

Bioresorbable Coronary Scaffolds Market: Drivers and Restraints

The primary factor driving the growth of global bioresorbable coronary scaffolds market is demand for safe and biocompatible coronary stents. Majority of big players in interventional cardiology market are actively involved in the development of bioresorbable coronary scaffolds. For instance, Medtronic Inc. is trying to develop completely bioresorbable stent for superficial femoral arteries under ‘Medtronic CardioVascular Bioabsorbable’ program.  Bioresorbable coronary scaffolds market is still in nascent stage and is expected to evolve gradually as new and improved products with drug eluting properties enter the market in nearest future. The biggest challenge in development of bioresorbable coronary scaffolds is selection of bioresorbable material. The material for bioresorbable coronary scaffolds should be biocompatible as well as it should degrade in minimum time. However, most of the materials proposed today require minimum 24 months for degrade fully.

  • Identify Key Market Forces and their Long-Term Forecast
  • Sneak Peek into Key Forecast Factors and thier Impact

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Bioresorbable Coronary Scaffolds Market: Overview

FDA approval of bioresorbable coronary scaffold is foreseen to take the huge leap forward in intervention cardiology market. Ongoing studies for development of bioresorbable coronary scaffold would bring couple of new products to the market in nearest future. The market is expected to expand steadily in emerging markets such as Japan and Latin America in next five years. The global market is expected to witness massive growth over the forecast period of 2017–2027 after approval of these devices in potential U.S. market. Manufacturers of these devices who already have approval in EU and some of Latin American countries are now seeing for approval in China, Japan and U.S.

Bioresorbable Coronary Scaffolds Market: Regional Outlook

Geographically, bioresorbable coronary scaffolds market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Europe so far dominated global bioresorbable coronary scaffolds market in 2016 and is expected to continue to do so due to more number of CE mark products in the market. Recently in April 2017, REVA Medical’s Fantom sirolimus-eluting bioresorbable scaffold received CE mark. North America bioresorbable coronary scaffolds market shows delayed growth due to late entry of highly potential products in the U.S. market.

Bioresorbable Coronary Scaffolds Market: Key Players

Some of players identified in bioresorbable coronary scaffolds market are Amaranth Medical, Inc., REVA Medical, Inc., Abbott Vascular Inc. (Abbott Laboratories Inc.), Elixir Medical Corporation, BIOTRONIK, Inc. among others. Moreover, according to literature review for bioresorbable coronary scaffolds, approximately 16 new device are in pipeline of various big players in interventional cardiology market, including Medtronic Inc., Boston Scientific Corporation among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Argentina)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic, Rest of Western Europe)
  • Eastern Europe (Russia, Poland)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Bioresorbable Coronary Scaffolds Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Bioresorbable Coronary Scaffolds Market: Segmentation

Tentatively, the global bioresorbable coronary scaffolds market has been segmented on the basis of product type, material, end user, and geography.

Based on product type, the global bioresorbable coronary scaffolds market is divided into following:

  • Drug Eluting Coronary Scaffolds
  • Everolimus-eluting Device (Absorb GT1)
  • Novolimus-eluting Device (DESolve)
  • Sirolimus-eluting Device
  • Paclitaxel-eluting device

Based on material, global bioresorbable coronary scaffolds market is segmented as below

  • Polyglycolic acid (PGA) Polymers
  • Polyglycolide Polymers
  • Bioresorbable Magnesium

Based on end user, global bioresorbable coronary scaffolds market is segmented as below:

  • Hospitals
  • Ambulatory Surgical Centers
  • Coronary Catheterization Labs

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Bioresorbable Coronary Scaffolds Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Bioresorbable Coronary Scaffolds Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch

Harish Tiwari

Global Head - Business Development

Akshay Godge

Client Partner - Global Business Development

Our Clients

Request Sample Request customization Request Methodology